Histological subclassification of G3 panNENs was not routinely assessed in our cohort in the previous years and therefore our results should be interpreted with caution, especially regarding a potential influence of the G3 NEC subtype affecting preoperative CRP, recommended treatment options, and patient outcome. The gene discussed is CRP; the disease is neuroendocrine carcinoma.